CV Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- CV Therapeutics's estimated annual revenue is currently $89.9M per year.
- CV Therapeutics's estimated revenue per employee is $155,000
Employee Data
- CV Therapeutics has 580 Employees.
- CV Therapeutics grew their employee count by -16% last year.
CV Therapeutics's People
| Name | Title | Email/Phone |
|---|
CV Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is CV Therapeutics?
CV Therapeutics, Inc. is a biopharmaceutical company headquartered in Palo Alto, CA. Focused on the development of novel small molecule therapeutics for the treatment of cardiovascular diseases, CV Therapeutics has emerged as a leader in cardiovascular medicine. In April 2009, CV Therapeutics was acquired by Gilead Sciences, Inc.
keywords:N/A
N/A
Total Funding
580
Number of Employees
$89.9M
Revenue (est)
-16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Palo Alto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $107.7M | 585 | -18% | $747.4M |
#2 | $104M | 594 | N/A | N/A |
#3 | $300M | 599 | 13% | $263.3M |
#4 | $110M | 607 | -45% | N/A |
#5 | $57M | 625 | 44% | $434M |